Today: 10 June 2026
Browse Category

Gold Prices 26 January 2026 - 30 January 2026

Gold price today: $5,600 record streak keeps traders watching Iran, Fed chair pick

Gold price today: $5,600 record streak keeps traders watching Iran, Fed chair pick

Spot gold hit a record $5,594.82 an ounce early Thursday before easing to $5,516.71, up 2.2%. U.S.-Iran tensions and a weaker dollar fueled safe-haven demand. The Fed left rates unchanged Wednesday, with Chair Powell signaling patience. U.S. February gold futures peaked at $5,626.80, while SPDR Gold Trust holdings reached their highest since May 2022.
29 January 2026
···
Antofagasta stock price jumps 6% as gold outlook rises and costs fall, despite copper miss

Antofagasta stock price jumps 6% as gold outlook rises and costs fall, despite copper miss

Antofagasta shares jumped 6% in early London trading after the miner reported a 9% rise in fourth-quarter copper output and lower net cash costs. Full-year copper production slipped 1.6% to 653,700 tonnes, while gold and molybdenum output rose sharply. The company kept its 2026 copper forecast and set capital spending at $3.4 billion. Non-executive director Andrónico Luksic Craig resigned, with Andrónico Luksic Lederer joining the board in March.
29 January 2026
···
Northern Star share price jumps 3% as gold hits record highs — what to watch next for ASX:NST

Northern Star share price jumps 3% as gold hits record highs — what to watch next for ASX:NST

Northern Star shares rose 3.1% to A$29.49 Thursday, outperforming a flat market as gold hit record highs and spot bullion settled up 2.6% at $5,538.69 an ounce. The miner, which recently cut FY26 output guidance and raised cost forecasts, reported December-quarter gold sales of 348,061 ounces at an AISC of A$2,937 per ounce. Investors await half-year results on Feb. 12 for updates on costs and production.
29 January 2026
···
FTSE 100 today slips as pound jumps and gold hits $5,300; Marston’s dives

FTSE 100 today slips as pound jumps and gold hits $5,300; Marston’s dives

FTSE 100 fell 0.3% to 10,177.85 as a stronger pound hit overseas earners. Gold reached a record above $5,300 an ounce, boosting miners, while Marston’s dropped up to 16% on flat 17-week sales. Traders awaited the U.S. Fed’s policy decision later Wednesday. Oil prices eased but held near four-month highs after U.S. supply disruptions.
28 January 2026
········
Northern Star Resources share price jumps 3.6% as gold tops $5,200; investors eye Feb 12 results

Northern Star Resources share price jumps 3.6% as gold tops $5,200; investors eye Feb 12 results

Northern Star Resources closed up 3.6% at A$28.71 as gold hit a record $5,247.21 an ounce before settling near $5,243.58. The company recently cut its FY26 production forecast and raised cost guidance to A$2,600–A$2,800 an ounce. Australian inflation data has fueled speculation of a February rate hike. Traders are watching U.S. dollar moves and upcoming Reserve Bank and Federal Reserve decisions.
28 January 2026
··
BHP share price hits new high on ASX as gold tops $5,200 and RBA hike bets build

BHP share price hits new high on ASX as gold tops $5,200 and RBA hike bets build

BHP shares closed up 1.8% at A$50.64, reaching a 52-week high as core inflation in Australia jumped past forecasts, fueling bets on an RBA rate hike next week. The S&P/ASX 200 slipped 0.1%, with gains in resource stocks offset by declines elsewhere. The Australian dollar hit a three-year high above 70 U.S. cents. Traders are watching BHP’s interim results and commodity price swings.
28 January 2026
···
Fresnillo PLC share price slips in London after gold’s $5,000 surge — what investors watch next

Fresnillo PLC share price slips in London after gold’s $5,000 surge — what investors watch next

Fresnillo shares fell 3.2% to 4,304 pence in early London trading Tuesday, retreating from Monday’s 6.7% surge and recent highs. The drop comes ahead of the company’s quarterly production report due Wednesday, with gold and silver prices hovering near records on safe-haven demand. Fresnillo recently completed a C$770 million acquisition of Probe Gold.
27 January 2026
··
Freeport-McMoRan stock hits a 52-week high, then cools — FCX traders track gold’s $5,100 run and Fed week

Freeport-McMoRan stock hits a 52-week high, then cools — FCX traders track gold’s $5,100 run and Fed week

Freeport-McMoRan hit a 52-week high Monday before closing up 1.26% at $61.17. Gold surged past $5,100 an ounce, drawing investors to miners, while copper hovered near $6 a pound ahead of the Federal Reserve’s Jan. 28 decision. Freeport’s gains followed strong earnings despite ongoing disruptions at its Grasberg mine in Indonesia.
27 January 2026
·····
Newmont stock price: why NEM rose as gold tops $5,100 and Scotiabank lifts target to $152

Newmont stock price: why NEM rose as gold tops $5,100 and Scotiabank lifts target to $152

Newmont shares rose 1.3% to $125.92 in after-hours trading Monday as gold prices hit a record $5,100 an ounce. Trading volume reached about 13.1 million shares. Scotiabank raised its price target for Newmont to $152, citing economic uncertainty and higher gold forecasts. The company’s Boddington mine in Australia resumed operations at reduced capacity after bushfires, with a Q1 production shortfall expected.
26 January 2026
······
1 2 3 4 5 … 9

Stock Market Today

  • Ondas Shares Slip Premarket After 2.7 Million-Share SEC Filing
    June 10, 2026, 5:37 AM EDT. Ondas Inc. shares fell 1.45% premarket to $9.51 following a June 9 SEC filing registering 2.7 million shares for resale tied to its $196.6 million acquisition of Israel's Omnisys Ltd. The filing signals no new capital raised but adds potential selling supply, pressuring the volatile defense-drone stock. Despite a 6.31% drop Tuesday, Ondas posted a 10-fold revenue increase to $50.1 million in Q1 and aims for $390 million revenue in 2026. CEO Eric Brock highlighted a $457 million backlog and strong order flow exceeding $110 million this quarter, underscoring growth in integrated defense tech and automation demand.

Latest articles

Micron Stock’s $1 Trillion AI Test Is Here as Traders Look to June 24

Micron Stock’s $1 Trillion AI Test Is Here as Traders Look to June 24

10 June 2026
Micron shares fell 1.5% to $935.89 as the AI-chip rally cooled, despite bullish analyst calls and price targets up to $1,625; investors await the June 24 earnings report to see if tight memory chip supply and AI demand can sustain the stock’s trillion-dollar valuation amid broader market jitters and shifting sentiment.
Ondas Stock Comes Back Into the Spotlight After 13% Drop; Drone Trade Faces Fresh Challenge

Ondas Dips Premarket After 2.7 Million-Share Filing

10 June 2026
SoFi Technologies traded near $16.47 in early premarket, little changed as investors weighed its AI and digital asset product push against a risk-off market mood, with no fresh earnings news and inflation data looming that could impact rates, loan demand, and fintech valuations.
Ondas Dips Premarket After 2.7 Million-Share Filing

SoFi Stock Holds Ahead of Pre-Market Test as Wall Street Grows Defensive

10 June 2026
Rolls-Royce shares rebounded 1.5% in London after Tuesday’s 2.68% drop, as investors weighed fresh airline criticism over engine delays against the company’s reaffirmed 2026 profit and cash flow guidance; CEO Tufan Erginbilgic said Rolls had a “strong start to the year,” but risks remain if airline pressure leads to higher costs or slower cash conversion.
LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

10 June 2026
LVMH shares slipped 0.49% to €489.90 in Paris after a four-day rebound, as investors weighed RBC’s reiterated Buy rating with a €600 target against ongoing 2026 losses and a 24% year-to-date drop; all eyes now turn to July’s first-half results for signs of recovery in Fashion & Leather Goods and any relief from Middle East weakness.
Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

10 June 2026
Roche’s participation certificates climbed 1.07% to CHF 322.20 after announcing a $2.3 billion deal with Nurix Therapeutics for late-stage blood-cancer drug bexobrutideg, planned to enter Phase 3 trials this summer in CLL, as investors weigh the asset’s potential to offset losses from expiring patents and drive mid-single-digit sales growth in 2026.
Go toTop